← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Director Jason P Rhodes sold $2.7M of Replimune Group, Inc.

Sold$2,749,721
$42.28Price
65,029Shares
−77%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Tue, Dec 15. Filed Thu, Dec 17, 6:21 PM ET, after the close. Not investment advice.